Prism Johnson Sells 51% Raheja QBE Stake for ₹324 Cr

BANKINGFINANCE
Whalesbook Logo
AuthorAkshat Lakshkar|Published at:
Prism Johnson Sells 51% Raheja QBE Stake for ₹324 Cr
Overview

Prism Johnson Limited will sell its entire 51% stake in Raheja QBE General Insurance Company Limited for ₹324 crore to QBE Holdings (AAP) Pty Limited. This transaction marks the end of the joint venture with Australia's QBE Group in the general insurance sector. The divestment is expected to be completed within nine months, pending shareholder and IRDAI approvals.

Prism Johnson Exits Insurance JV, Sells Raheja QBE Stake for ₹324 Crore

Prism Johnson Limited has announced the sale of its entire 51% stake in Raheja QBE General Insurance Company Limited for an aggregate consideration of Rs. 324 crore. The divested subsidiary contributed ₹498.91 crore in revenue and ₹253.66 crore in networth as of March 31, 2025.

Reader Takeaway: Cash infusion from divestment; regulatory approvals critical for deal completion.

What just happened (today’s filing)

Prism Johnson Limited has agreed to sell its complete 51% shareholding in its material unlisted subsidiary, Raheja QBE General Insurance Company Limited (RQBE). [cite:Filing]

The transaction is valued at an aggregate consideration of Rs. 324 crore, to be paid by QBE Holdings (AAP) Pty Limited. [cite:Filing]

This sale will lead to the termination of the company's joint venture with Australia's QBE Group in the general insurance business in India. [cite:Filing]

RQBE represented 6.82% of Prism Johnson's consolidated turnover and 17.16% of its consolidated networth as of March 31, 2025. [cite:Filing]

Why this matters

The divestment signals a strategic pivot for Prism Johnson, allowing it to exit the insurance sector and sharpen its focus on its core building materials business. [cite:Filing, 2, 3, 4, 5, 10]

The substantial cash inflow of ₹324 crore provides the company with financial flexibility. This could be used for further investment in its primary segments like cement, tiles, and RMC, or for debt reduction. [cite:Filing]

The backstory (grounded)

Prism Johnson Limited, formerly known as Prism Cement Limited, was incorporated in 1992.

The company previously reduced its stake in Raheja QBE General Insurance Company Limited from 74% to 51% in 2016 by selling shares to QBE Asia Pacific Holdings Limited for Rs 111.04 crore.

An earlier attempt in July 2020 to divest 51% of RQBE to QORQL Pvt Ltd (associated with Paytm) for approximately Rs 290 crore appears to have not materialized or was superseded.

In July 2024, Prism Johnson had acquired shares in RQBE on a rights basis for ₹20.41 crore, maintaining its 51% shareholding, indicating continued commitment to the subsidiary prior to this sale.

What changes now

  • Raheja QBE General Insurance Company Limited will cease to be a subsidiary of Prism Johnson Limited.
  • The joint venture relationship between Prism Johnson and Australia's QBE Group in the general insurance business will be terminated.
  • The company's financial exposure to the general insurance sector will be eliminated.

Risks to watch

The transaction is subject to certain conditions precedent, including the receipt of necessary approvals from Prism Johnson's shareholders and the IRDAI. [cite:Filing]

The final consideration is subject to potential adjustments upon the completion of the transaction. [cite:Filing]

Peer comparison

Prism Johnson is exiting a sector populated by major players like ICICI Lombard General Insurance, HDFC ERGO General Insurance, SBI General Insurance, and Bajaj Allianz General Insurance, all of which operate significant general insurance businesses in India.

Context metrics (time-bound)

  • The sale consideration for the 51% stake is ₹324.00 crore, as of FY25.
  • The subsidiary contributed ₹498.91 crore in revenue as of March 31, 2025, representing 6.82% of the consolidated turnover.
  • The subsidiary's networth was ₹253.66 crore as of March 31, 2025, accounting for 17.16% of the consolidated networth.

What to track next

  • Monitor the progress of obtaining shareholder approval from Prism Johnson.
  • Track the receipt of the crucial IRDAI (Insurance Regulatory and Development Authority of India) approval for the transaction.
  • Observe any adjustments to the sale consideration as the deal progresses towards completion.
  • Analyze how Prism Johnson plans to deploy the proceeds from the sale, focusing on its core business segments.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.